Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
about
One-shot, low-dosage intratympanic gentamicin for Ménière's disease: Clinical, posturographic and vestibular test findings.Nanotechnology and the treatment of inner ear diseases.A network-based method using a random walk with restart algorithm and screening tests to identify novel genes associated with Menière's disease.Chemical labyrinthectomy for the worse ear of adult Nigerians with bilateral Meniere's disease: preliminary report of treatment outcomes.Vestibular results after intratympanic gentamicin therapy in disabling Menière's disease.Mitochondrial ribosome and Ménière's disease: a pilot study.
P2860
Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intratympanic gentamicin treat ...... s disease with normal hearing.
@en
Intratympanic gentamicin treat ...... s disease with normal hearing.
@nl
type
label
Intratympanic gentamicin treat ...... s disease with normal hearing.
@en
Intratympanic gentamicin treat ...... s disease with normal hearing.
@nl
prefLabel
Intratympanic gentamicin treat ...... s disease with normal hearing.
@en
Intratympanic gentamicin treat ...... s disease with normal hearing.
@nl
P2093
P2860
P1476
Intratympanic gentamicin treat ...... s disease with normal hearing.
@en
P2093
Herbert Silverstein
Jack Wazen
Julie Daugherty
Mark J Van Ess
Yadiel A Alameda
P2860
P304
P356
10.1016/J.OTOHNS.2009.12.009
P577
2010-04-01T00:00:00Z